Dr. Imran Y. Nizami, MD

Dr. Nizami practices at INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health.

Dr. Nizami's NPI, 1407865611, was assigned on August 5, 2006. Dr. Nizami holds Oklahoma license 22552.

Dr. Nizami's primary practice is INTEGRIS Health Baptist Medical Center, at 3300 Northwest Expressway, Oklahoma City, OK 73112 in Oklahoma County. The practice phone is (405) 949-3011.

Dr. Nizami's primary practice is INTEGRIS Health Baptist Medical Center in Oklahoma City, Oklahoma, part of INTEGRIS Health. The medical group on file is INTEGRIS Health Cardiovascular Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nizami practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Nizami's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Nizami is licensed in Oklahoma.

CMS data shows 381 Medicare services from Dr. Nizami across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $14,211 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Nizami in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 3.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nizami's median patient age at 68, with 50% women.

In 2024, Dr. Nizami wrote 842 Medicare Part D claims for 90 patients. 90% of them were for generic drugs. CMS names the drug for 580 of them, across 23 drugs with 11 or more claims each, at $93,454 in total drug cost. In 2023, CMS named 82 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Nizami for performance year 2024, reported as part of a group.

Dmand AI links 21 papers to Dr. Nizami, published from 2013 to 2022. 2020 was the busiest year, with 5. The most frequent topics are Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Lung Transplantation. Dr. Nizami has published most often in Ann Saudi Med. Dr. Nizami's most frequent co-authors are Majed J. Dasouki, MD, Mohamed Zaghloul Bayoumy Aly Hussein, MD and Shahrukh K. Hashmi, MD.

CMS Open Payments shows 2 general payments to Dr. Nizami from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $149.